Search results
Showing 121 to 135 of 496 results for 2011
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography (HTG429)
Evidence-based recommendations on HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography.
Evidence-based recommendations on azacitidine (Vidaza) for treating myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia in adults.
Psychosis and schizophrenia in children and young people: recognition and management (CG155)
This guideline covers recognising and managing psychosis and schizophrenia in children and young people. It aims to improve early recognition of psychosis and schizophrenia so that children and young people can be offered the treatment and care they need to live with the condition.
NICE has developed a medtech innovation briefing (MIB) on the Shiley Endotracheal Tube with TaperGuard Cuff .
MiraQ for assessing graft flow during coronary artery bypass graft surgery (HTG275)
Evidence-based recommendations on MiraQ for assessing graft flow during coronary artery bypass graft surgery.
Day-to-day decision making is the responsibility of NICE's executive team.
The Arrow OnControl powered bone marrow biopsy system for bone marrow aspiration and biopsy (MIB19)
NICE has developed a Medtech Innovation Briefing (MIB) on the ARROW OnControl powered bone marrow biopsy system for bone marrow aspiration and biopsy
Summary of the evidence on bevacizumab 7.5 mg/kg with paclitaxel and carboplatin for the first-line treatment of advanced ovarian cancer..
What proxy outcome measures are suitable for studies of the primary prevention of skin cancer?
Skin cancer prevention Number PH32 Date issued January 2011 Other details Is this a recommendation for the use
coronary syndromes Number TA236 Date issued October 2011 Other details Is this a recommendation for the use
Evidence-based recommendations on Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers.
cryotherapy for renal cancer Number IPG405 Date issued August 2011 Other details Is this a recommendation for the use
coronary syndromes Number TA236 Date issued October 2011 Other details Is this a recommendation for the use
What risk factors predict the onset of substance misuse in young people with psychosis?
in healthcare settings Number CG120 Date issued March 2011 Other details Is this a recommendation for the use
treatment of osteosarcoma Number TA235 Date issued October 2011 Other details Is this a recommendation for the use